Corrigendum to "Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia" [Vaccine 36 (2018) 4939-4943]
Vaccine. 2020 Mar 17;38(13):2887.
doi: 10.1016/j.vaccine.2020.02.033.
Epub 2020 Feb 25.
1 Expanded Programme on Immunization (EPI), Department of Immunizations, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland. Electronic address: ahasan7@jhmi.edu.
2 Child Health Research Foundation, Dhaka Shishu Hospital, Dhaka, Bangladesh.
3 Child Health Research Foundation, Dhaka Shishu Hospital, Dhaka, Bangladesh; Bangladesh Institute of Child Health, Dhaka Shishu Hospital, Dhaka, Bangladesh.
4 National Immunization Program, Armenia National Center of Disease Control and Prevention, Armenia & Ministry of Health of the Republic of Armenia, Yerevan, Armenia.
5 National Center of Disease Control and Prevention, Armenia Ministry of Health of the Republic of Armenia & Immunization and Epidemiology of Vaccine-Preventable Diseases, Yerevan, Armenia.
6 The World Health Organization, Regional Office for Africa, Brazzaville, Congo.
7 Vaccines and Immunity Theme, Medical Research Council Unit, Fajara, Gambia.
8 Department of International Health, Johns Hopkins University, Baltimore, MD, United States.
9 Expanded Programme on Immunization (EPI), Department of Immunizations, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
10 WHO Regional Office for South-East Asia, New Delhi, India.
11 National Center of Disease Control and Prevention, Armenia & Ministry of Health of the Republic of Armenia, Armenia.
12 Nork Infection Hospital, Yerevan, Armenia.
13 Arabkir Medical Center, Yerevan, Armenia.
14 Ministry of Health of the Republic of Armenia, Armenia.
15 Vaccine-Preventable Diseases and Immunization, WHO Regional Office for Europe, Copenhagen, Denmark.